New Initiative Seeks to Improve Chronic Illness Management
The UC Academic Health Center has joined a national collaborative that will work to improve the care of patients with chronic illness.
Chronic (long-term or frequent) illness affects more than 100 million Americans. Eighty percent of Medicare recipients have one or more chronic illnesses, which account for about 75 of percent U.S. health-care dollars spent.
UC will work with the Health Alliance, Cincinnati Childrens Hospital Medical Center and teams around the country to better define programs and identify best practices for managing chronic illnesses such as asthma, depression, diabetes, hypertension and chronic heart failure, among others.
This year-long initiative, called the Academic Chronic Care Collaborative, is a partnership between the Association for Academic Medical Colleges and Improving Chronic Illness Care, a national program of the Robert Wood Johnson Foundation.
As a whole, the U.S. is set up very much as an acute-care system (for rapidly developing illnesses), says T.J. Redington, MD, who will head the chronic-care teams, yet most of the patients we see are living with chronic illness.
Its important that we come up with strategies for managing chronic illness in our clinics and hospitals, says Dr. Redington, internal medicine professor at UC, community health director for the Health Alliance and medical director for Ohios Medicaid program.
Physicians, nurses and allied health professionals from a variety of practices and clinics have identified target chronic conditions to manage. They will study a number of sites, including Hoxworth Medicine Clinic, Hoxworth Medicine-Pediatrics Clinic, Wyoming Family Medicine Practice, Childrens Pediatric Primary Care Center, the Internal Medicine Clinic at Christ Hospital and the Consumer Wellness Clinic.
Tags
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.
Heavy social media use linked to depression
August 31, 2026
U.S. News and World Report, Yahoo! News, MSN, USA Today and other national media highlight a new study by the University of Cincinnati and Northwestern University that found a correlation between heavy social media use and depression in adults.